Delivery Order SPE2DB22D3011-SPE2DB24FQ1VM
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,325.24 to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,580.34 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. This contract is for the supply of 4564658894 ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, with a completion date of May 21, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive...
- The U.S. Defense Logistics Agency (DLA) awarded a $11,234.68 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM. The contract has an ultimate completion date of April 29, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA)...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $16,844.93 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ADVAIR HFA 115-21 MCG INHALER 12GM pharmaceuticals. This delivery order was issued under an existing indefinite delivery contract (IDC) worth up to $999,999,999.00 held by Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $4,741.43 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Advair HFA 45-21 MCG Inhaler 12GM. This is an order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. As a major supplier of pharmaceutical products and medical supplies to federal agencies,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $10,260.79 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply ADVAIR HFA 115-21 MCG INHALER 12GM. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,458,621 units of ADVAIR HFA 230-21 MCG INHALER 12GM. The $2,117.85 contract has a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC)...
- The federal government has awarded a delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, to supply 4,565,320,989 units of the ADVAIR HFA 115-21 MCG INHALER 12GM product. The $2,206.12 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, with an ultimate completion date of August 2, 2024. This award is part of Amerisourcebergen's broader Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $17,666.38 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM. The delivery order was issued under an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract...
- The Defense Logistics Agency (DLA) awarded a $2,981.79 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB24FQ1VMDelivery Order
The U.S. Defense Logistics Agency (DLA) has awarded a Delivery Order contract worth $12,949.35 to Amerisourcebergen Drug Corp's Corporate Office Division to supply 4,564,857,521 units of the ADVAIR HFA 230-21 MCG INHALER 12GM pharmaceutical product. This is a firm fixed-price contract with a completion date of June 11, 2024. Amerisourcebergen, a major pharmaceutical distribution company, is leveraging its extensive supply chain capabilities to fulfill this order for the DLA, which supports the Department of Defense's medical needs. The contract is not set aside and was awarded on a full and open competition basis, highlighting Amerisourcebergen's competitive position in the federal pharmaceutical supply market. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the DLA Troop Support Medical, as well as a smaller IDC with the Department of Justice Federal Bureau of Investigation valued up to $750,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.9k | 6/10/24 |